GAD1 and Anxiety: After adjusting for sociodemographic, clinical, and HIV treatment-related factors, there was no association between COVID-19-related anxiety (AOR = 1.00 (95% CI 1.00, 1.01); p = .862) or GAD (AOR = 1.01 (0.98, 1.05); p = .468) and visit adherence.